Verrica Pharmaceuticals (VRCA) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.37
-0.25
-0.12
0

Details

Expected EPS
-0.19
Actual EPS
-0.13
Surprise EPS
0.06
Surprise Percent
+31.58%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.13 per share for Q1 2023.

0 Comments

Share your thoughts